Neurofibromatosis Type 1 Related Hydrocephalus.

Neurol India

Department of Pediatric Neurosurgery, Dana Children's Hospital, Tel-Aviv Medical Center, Tel-Aviv University; The Gilbert Israeli International Neurofibromatosis Center GIINFC, Tel-Aviv, Israel.

Published: February 2022

The prevalence of hydrocephalus among patients with neurofibromatosis type I (NF1) is estimated to be between 1 and 13%. Aqueductal webs, chiasmatic-hypothalamic tumors, and thalamic mass effect related to NF changes are the common causes of NF1-related hydrocephalus. Brain tumors and moyamoya syndrome may mimic the clinical presentation of hydrocephalus in children with NF1, and should be ruled out while evaluating children with headaches. Treatment of NF1-related hydrocephalus should be personally tailored, including shunts, endoscopic procedures such as septostomy and third ventriculostomy, and tumor resection or debulking. Despite these personalized treatments, many of the primary treatments (including shunts and endoscopic procedures) fail, and patients should be screened and followed accordingly. In the current manuscript, we review the causes of NF1-related hydrocephalus, as well as treatment options.

Download full-text PDF

Source
http://dx.doi.org/10.4103/0028-3886.332254DOI Listing

Publication Analysis

Top Keywords

nf1-related hydrocephalus
12
neurofibromatosis type
8
including shunts
8
shunts endoscopic
8
endoscopic procedures
8
hydrocephalus
6
type hydrocephalus
4
hydrocephalus prevalence
4
prevalence hydrocephalus
4
hydrocephalus patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!